CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Core Viewpoint - CareDx, Inc. reported preliminary, unaudited financial results for the fourth quarter and full year 2025, highlighting significant revenue growth in the transplant healthcare sector [1]. Financial Performance - The company achieved revenue of approximately $108 million in the fourth quarter of 2025, representing a 25% increase year-over-year [1].